| |
 |
|
| |
Janssen-Cilag originates from two pharmaceutical
companies: Janssen Pharmaceutica and Cilag.
Janssen Pharmaceutica was established in 1953 in
Belgium (Beerse) by a young medical doctor, Dr Paul
Janssen. Success came quickly, for the fifth molecule
synthesized was found to have therapeutic properties.
Many more innovations were to follow, in fields
as diverse as gastroenterology, psychiatry, neurology,
allergy, mycology and pain management. In 1961,
Janssen Pharmaceutica joined the Johnson & Johnson
group of companies. With more than 80 drugs to its
name (five of which feature on the WHO's list of
essential drugs), Janssen Pharmaceutica continues
to be one of the most innovative companies in the
world.
Cilag (an acronym formed from the initial letters
of Chemical Industry Laboratory AG) was founded
by Dr Joos, a doctor in chemistry, who set up a
small research laboratory in Switzerland (Schaffhausen)
in 1933 and then founded Cilag in 1936. His first
discovery was pyridazil, a disinfectant for the
kidneys and urinary tract. By 1952 he had discovered
seven new chemical compounds and developed them
into new products. In 1959, Cilag joined the Johnson
& Johnson group of companies. The company's R&D
track record covers discoveries and developments
in the fields of biotechnology, central nervous
system, women's health, dermatology, anti-infectives
and immunology.
Many Janssen-Cilag drugs represented "firsts" in
their class at the time they were introduced and
have blazed the trail for other products that have
followed.
For more information,visit www.janssen-cilag.com |
|
| |
|
|
| |
|
|
 |
|
|
|
| |
ALZA Corporation
ALZA Corporation is a research-based pharmaceutical
company and a leader in drug delivery technologies.
ALZA technologies optimize and control how
medicines are delivered into and within the
body, enhancing therapeutic value, and potentially
reducing side effects and improving tolerability.
www.alza.com
|
|
|
|
|
|
|
